The platform currently supports a network of more than 4,500 clinics across all 50 U.S. states and territories. With a month-over-month growth rate of 20 percent and an 85 percent client retention rate, the service has become a primary infrastructure tool for high-volume medical operations specializing in weight management, hormone therapy, and wellness.
In section Releases
WellSync’s BoomRx Hits $70 Million Run Rate as Clinic Adoption Surges
Less than a year after its July 2025 launch, pharmaceutical technology platform BoomRx has eclipsed a $70-million annualized run rate. The Tampa-based subsidiary of WellSync is now handling over 40,000 monthly orders, signaling a rapid shift toward automated prescription management for virtual-care providers nationwide.
WellSync CEO Fabian Calvo attributes the growth to the platform’s ability to bypass traditional administrative bottlenecks in prescription sourcing. By consolidating multi-pharmacy workflows into a single portal, the system assists clinics in navigating complex state-by-state shipping requirements and pharmaceutical supply-chain volatility. According to BoomRx co-founder and president Kurt Lunkwitz, recent technical updates were specifically engineered to curb industry-wide risks such as counterfeit medications and improper storage, while simultaneously accelerating order fulfillment for providers.
Comments (0)
No comments yet. Be the first!